Evidence map›Paper›PMID 42177779›Full record

ArticleCancer reports (Hoboken, N.J.)2026

Development of a Machine Learning Model for Distant Metastasis Risk Stratification in Acral Melanoma.

Ye Shanyuan, Zhang Rundong, Cao Meng, Qiu Zequn, Zhang Qian, Lv Qun, Wang Yan

Abstract read
In one paragraph

Article in Cancer reports (Hoboken, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ye ShanyuanHospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, Jiangsu, China.ORCID 0009-0008-8461-6254
Zhang RundongHospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, Jiangsu, China.ORCID 0000-0001-5723-675X
Cao MengHospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, Jiangsu, China.ORCID 0000-0002-3500-8390
Qiu ZequnHospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, Jiangsu, China.ORCID 0009-0009-5943-1116
Zhang QianHospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, Jiangsu, China.ORCID 0000-0002-2385-5779
Lv QunHospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, Jiangsu, China.ORCID 0000-0002-8266-2176
Wang YanHospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, Jiangsu, China.ORCID 0000-0002-3829-8792

Funding

CAMS Innovation Fund for Medical Sciences 2024-I2M-C&T-B-089Jiangsu Commission of Health Scientific Research Project M2024012National Key Research and Development Program of China 2022YFC2504700National Key Research and Development Program of China 2022YFC2504701National Key Research and Development Program of China 2022YFC2504705National Natural Science Foundation of China 81872216
6 · The paper itself

Abstract

backgroundAcral melanoma (AM) is a distinct melanoma subtype associated with delayed diagnosis, aggressive progression, and poor prognosis once distant metastasis occurs. However, prediction models specifically designed for distant metastasis risk stratification in AM remain limited.

aimsThis study aimed to develop and internally evaluate a machine learning-based model for individualized distant metastasis risk stratification in patients with AM. METHODS AND

resultsClinical data of 1822 patients with AM diagnosed between 2000 and 2021 were extracted from the SEER database. Patients were divided into training and internal test sets at a ratio of 7:3 using stratified sampling. Logistic regression analyses were performed to identify factors associated with distant metastasis, and six machine learning algorithms were developed and compared. SMOTE was applied only to the training set to address class imbalance. Multivariate logistic regression identified sentinel lymph node biopsy as an independent protective factor, whereas higher N stage and lower median household income were independent risk factors. Among the evaluated models, LightGBM showed relatively balanced overall performance and was selected as the optimal model. SHAP analysis identified N stage, sentinel lymph node biopsy record, and median household income as the most important predictors.

conclusionThe LightGBM model demonstrated moderate predictive performance for distant metastasis risk stratification in patients with AM. This model may serve as a research-oriented tool for individualized risk assessment, although external validation using independent real-world cohorts is required before clinical application.

Indexed as

Machine LearningMelanomaSkin NeoplasmsAdultAgedBoosting Machine Learning AlgorithmsClassification AlgorithmsFemaleHumansMaleMiddle AgedNeoplasm MetastasisNeoplasm StagingPrediction AlgorithmsPredictive Learning ModelsPrognosisacral melanomadistant metastasisLightGBMmachine learningprediction model

Identifiers

PMID42177779
PMCPMC13240029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.